The effect of lipid lowering medication on lipid accumulation in patients with neutral lipid storage disease with muscle weakness. The effect of lipid lowering medication on lipid accumulation in patients with neutral lipid storage ...
The effect of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSDM). - Fibrate Trail The effect of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSD ...
Neutral lipid storage disease with myopathy MedDRA version: 13.1;Level: PT;Classification code 10007636;Term: Cardiomyopathy;System Organ Class: 10007541 - Cardiac disorders MedDRA version: 13.1;Level: HLGT;Classification code 10013317;Term: Lipid metabolism disorders;System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 13.1;Classification code 10028641;Term: Myopathy;System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03] Neutral lipid storage disease with myopathy MedDRA version: 13.1;Level: PT;Classification code 10007 ...